AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:10 2024-05-17 am EDT			5-day change	1st Jan Change
12,110 ^GBX	-0.46%		-2.10%	+14.25%

May. 17	Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	RE
May. 16	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	MT

ASTRAZENECA : Deutsche Bank gives a Neutral rating

April 30, 2024 at 09:34 am EDT

Initially Neutral on the company, Deutsche Bank's analyst Emmanuel Papadakis maintained his recommendation. The target price is still set at GBX 11000.

Latest news about AstraZeneca PLC

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	May. 17	RE
AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	May. 16	MT
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	May. 16
AstraZeneca trials yield positive results for immunocompromised patients	May. 16	AN
AstraZeneca: positive results in Covid prevention	May. 16	CF
The FTSE 100 is taking a breather	May. 16
AstraZeneca's Antibody Cuts COVID-19 Risk Among Immunocompromised in Late-stage Study	May. 16	MT
AstraZeneca PLC Phase III Trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population	May. 16	CI
ASTRAZENECA : UBS reiterates its Sell rating	May. 15	ZD
FDA extends review of Ascendis Pharma's hormone disorder therapy	May. 14	RE
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	May. 13
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- 2nd Update	May. 13	DJ
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- Update	May. 13	DJ
Cinven to explore $3 billion sale of software maker Jaggaer, sources say	May. 13	RE
Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France	May. 13	MT
France Secures Billions at Foreign Investment Summit	May. 13	DJ
France gets $16 billion of foreign investments as part of 'Choose France' event	May. 13	RE
AstraZeneca Pledges $388 Million Investment at French Site	May. 12	MT
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France	May. 12	RE
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08	MT

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

12:15pm - American Thoracic Society Conference - Abstarct Number - P297

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

153.9 USD

Average target price

167.7 USD

Spread / Average Target

+9.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+14.25%	239B
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B
PFIZER, INC.	-0.52%	162B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

ASTRAZENECA : Deutsche Bank gives a Neutral rating

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals